Medical Bulletin 1/December/2021 - Video
Overview
Here are Top Medical stories of the day
COVID-19 linked to myocarditis in college athletes
A small but significant percentage of college athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation of the heart muscle, that can only be seen on cardiac MRI, according to a study being presented at the annual meeting of the Radiological Society of North America (RSNA).
Myocarditis, which typically occurs as a result of a bacterial or viral infection, can affect the heart's rhythm and ability to pump and often leaves behind lasting damage in the form of scarring to the heart muscle. It has been linked to as many as 20% of sudden deaths in young athletes. The COVID-19 pandemic raised concerns over an increased incidence of the condition in student-athletes.
For more details, check out the full details on the link below:
COVID-19 Linked To Myocarditis In College Athletes, Reveal MRI Findings
The number of missing teeth is the strongest predictor of mortality, according to a study published in the International Endodontic Journal.
A group of researchers conducted a study to determine whether oral parameters such as endodontic infections, root canal fillings, number of teeth or wearing removable dentures at baseline are associated with cardiovascular- and all-cause mortality in a follow-up of approximately 8 years.
For more details, check out the full details on the link below:
Number Of Missing Teeth Strongest Predictor Of Mortality: Study
Nebivolol is beneficial over atenolol with regards to glycemic control and serum lipid profile in type 2 diabetes patients with concomitant hypertension, reveals a recent study published in the Pakistan Journal of Pharmaceutical Sciences.
Blood pressure control in patients with hypertension and metabolic abnormalities is challenging as many antihypertensive drugs adversely affect metabolism. Nebivolol is a third-generation β-blocker, with the highest β(1) selectivity and nitric-oxide-derived vasodilatation. It also shows antioxidant and antiproliferative property that has a beneficial metabolic profile versus second-generation β blockers like atenolol.
For more details, check out the full details on the link below:
A new study led by researchers at UCLA Health has found that cognitive behavioral therapy (CBT-I) prevented major depression, decreasing the likelihood of depression by over 50% as compared to sleep education therapy in adults over the age of 60 with insomnia.
Their findings, reported today in JAMA Psychiatry, could advance public health efforts to effectively treat insomnia and prevent major depression disorder (MDD) in older adults – a growing population that is projected to rise from about 54 million Americans aged 65 and older today to about 86 million in 2050.
For more details, check out the full details on the link below:
Treatment Of Insomnia With Cognitive Behavioral Therapy Can Prevent Major Depression In Elderly
Speakers
